Literature DB >> 15832311

KinMutBase: a registry of disease-causing mutations in protein kinase domains.

Csaba Ortutay1, Jouni Väliaho, Kaj Stenberg, Mauno Vihinen.   

Abstract

A large number of disease-causing mutations have been identified from several protein kinases. KinMutBase is a comprehensive knowledge base for human disease-related mutations in protein kinase domains (http://bioinf.uta.fi/KinMutBase/). The latest version contains 582 different mutations for 1,790 cases in 1,322 families. KinMutBase entries are described on the DNA, mRNA, and protein level. Numbers for affected patients and families are also provided. KinMutBase has extensive amount of links and cross-references to literature, other databases, and information sources. There are numerous interactive pages about sequences, structures, mutation statistics, and diseases. Detailed statistical study was done on frequencies of different types of mutations both on the DNA and protein level in serine/threonine kinase (PSK) and tyrosine kinase (PTK). Three-dimensional structures indicate clustering of disease-related mutations mainly to conserved subdomains, and substrate and coligand binding amino acids, although mutations appear throughout the sequences. CpG containing codons, especially for arginine, constitute the majority of mutational hotspots. There are certain clear differences in mutation patterns and types between PSKs and PTKs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832311     DOI: 10.1002/humu.20166

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  30 in total

Review 1.  Peptide-based fluorescent sensors of protein kinase activity: design and applications.

Authors:  Vyas Sharma; Qunzhao Wang; David S Lawrence
Journal:  Biochim Biophys Acta       Date:  2007-08-15

2.  A helix scaffold for the assembly of active protein kinases.

Authors:  Alexandr P Kornev; Susan S Taylor; Lynn F Ten Eyck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-11       Impact factor: 11.205

3.  Congenital disease SNPs target lineage specific structural elements in protein kinases.

Authors:  Ali Torkamani; Natarajan Kannan; Susan S Taylor; Nicholas J Schork
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

4.  Expanding the conformational selection paradigm in protein-ligand docking.

Authors:  Guray Kuzu; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Methods Mol Biol       Date:  2012

5.  Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1.

Authors:  Ravichandran N Murugan; Jung-Eun Park; Dan Lim; Mija Ahn; Chaejoon Cheong; Taeho Kwon; Ky-Youb Nam; Sun Ho Choi; Bo Yeon Kim; Do-Young Yoon; Michael B Yaffe; Dae-Yeul Yu; Kyung S Lee; Jeong Kyu Bang
Journal:  Bioorg Med Chem       Date:  2013-02-27       Impact factor: 3.641

Review 6.  Kinase mutations in human disease: interpreting genotype-phenotype relationships.

Authors:  Piya Lahiry; Ali Torkamani; Nicholas J Schork; Robert A Hegele
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

Review 7.  Cancer driver mutations in protein kinase genes.

Authors:  Ali Torkamani; Gennady Verkhivker; Nicholas J Schork
Journal:  Cancer Lett       Date:  2008-12-10       Impact factor: 8.679

8.  Kinomer v. 1.0: a database of systematically classified eukaryotic protein kinases.

Authors:  David M A Martin; Diego Miranda-Saavedra; Geoffrey J Barton
Journal:  Nucleic Acids Res       Date:  2008-10-30       Impact factor: 16.971

9.  Sequence and structure signatures of cancer mutation hotspots in protein kinases.

Authors:  Anshuman Dixit; Lin Yi; Ragul Gowthaman; Ali Torkamani; Nicholas J Schork; Gennady M Verkhivker
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

10.  Extraction of human kinase mutations from literature, databases and genotyping studies.

Authors:  Martin Krallinger; Jose M G Izarzugaza; Carlos Rodriguez-Penagos; Alfonso Valencia
Journal:  BMC Bioinformatics       Date:  2009-08-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.